Metabolic Syndrome X
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
The presence of the rs12255372 and rs7903146 TCF7L2 gene variants plays an important role in the development of T2DM among individuals with MS.
|
29971604 |
2018 |
Metabolic Syndrome X
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
The results show that the genotype-phenotype for CC, CT/TT of TCF7L2 gene polymorphism correlated with body mass index and waist circumference in MetSyn and MetSyn + T2D subjects (<i>r</i> = -0.949 and <i>r</i> = -0.963, respectively).
|
28465699 |
2017 |
Metabolic Syndrome X
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, the TCF7L2 rs7903146 polymorphism influences MetS risk, which is augmented by both gender and dietary SFA intake, suggesting novel gene-diet-gender interactions.
|
21543200 |
2012 |
Metabolic Syndrome X
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
SNP in the TCF7L2 gene are associated with differences in insulin secretion, blood pressure, blood lipids and coagulation in MetS patients, and may be modulated by SFA in plasma or IR.
|
21115178 |
2011 |
Metabolic Syndrome X
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
The two markers located within the TCF7L2 gene showed strong associations with T2D (rs7903146, T allele, odd ratio (OR) = 1.76, p = 0.001 and rs12255372, T allele, OR = 1.78, p = 0.002), but did not show significant association with MS.
|
20503258 |
2010 |
Metabolic Syndrome X
|
0.180 |
GeneticVariation
|
disease |
GWASDB |
A genome-wide association study of the metabolic syndrome in Indian Asian men.
|
20694148 |
2010 |
Metabolic Syndrome X
|
0.180 |
GeneticVariation
|
disease |
GWASCAT |
A genome-wide association study of the metabolic syndrome in Indian Asian men.
|
20694148 |
2010 |
Metabolic Syndrome X
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
In summary, high (n-6) PUFA intakes (> or = 6.62% of energy intake) were associated with atherogenic dyslipidemia in carriers of the minor T allele at the TCF7L2 rs7903146 SNP and may predispose them to MetS, diabetes, and cardiovascular disease.
|
19141698 |
2009 |
Metabolic Syndrome X
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms in TCF7L2 (rs7903146, OR 1.10, 95% CI 1.04-1.17, p = 0.00097), FTO (rs9939609, OR 1.08, 95% CI 1.02-1.14, p = 0.0065), WFS1 (rs10010131, OR 1.07, 95% CI 1.02-1.13, p = 0.0078) and IGF2BP2 (rs4402960, OR 1.07, 95% CI 1.01-1.13, p = 0.021) predicted the development of at least three components of the metabolic syndrome in both univariate and multivariate analysis; in the case of TCF7L2, WFS1 and IGF2BP this was due to their association with hyperglycaemia (p < 0.00001, p = 0.0033 and p = 0.027, respectively) and for FTO it was due to its association with obesity (p = 0.004).
|
18853134 |
2008 |
Metabolic Syndrome X
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys.
|
17226113 |
2007 |